openPR Logo
Press release

Fecal Calprotectin Test Market New Highs - Current Trends and Growth Drivers 2023

The global fecal calprotectin test market is poised for substantial growth over the forecast period from 2023 to 2031, as reported by Market Insights & Analysis, a renowned market research firm. The market, which was valued at US$ 126.9 million in 2022, is projected to expand at a robust compound annual growth rate (CAGR) of 10.7% to reach more than US$ 355.8 million by the end of 2031.

๐—ฅ๐—ฒ๐—พ๐˜‚๐—ฒ๐˜€๐˜ ๐—ณ๐—ผ๐—ฟ ๐—ฎ ๐˜€๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ถ๐˜€ ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ฎ๐˜ (๐—จ๐˜€๐—ฒ ๐—–๐—ผ๐—ฟ๐—ฝ๐—ผ๐—ฟ๐—ฎ๐˜๐—ฒ ๐— ๐—ฎ๐—ถ๐—น ๐—œ๐—ฑ ๐—ณ๐—ผ๐—ฟ ๐—ค๐˜‚๐—ถ๐—ฐ๐—ธ ๐—ฅ๐—ฒ๐˜€๐—ฝ๐—ผ๐—ป๐˜€๐—ฒ) - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=78383

The surge in the prevalence of inflammatory bowel disease (IBD) and gastrointestinal disorders is a major driver propelling the growth of the fecal calprotectin test market. This diagnostic tool measures the level of calprotectin, a protein released during inflammation, in the stool. Particularly, it finds extensive use in adult patients due to the high incidence rate of IBD and colorectal cancer among this demographic. The growing awareness among patients and healthcare professionals regarding the benefits of early diagnosis and treatment is anticipated to bolster the global fecal calprotectin test market.

Companies operating in this sector are focused on developing more accurate and cost-efficient fecal calprotectin tests to gain a competitive edge and increase their market share. Despite these opportunities, challenges such as the high cost of tests and the absence of reimbursement policies in some regions are anticipated to hinder market growth.

๐—•๐˜‚๐˜† ๐˜๐—ต๐—ถ๐˜€ ๐—ฃ๐—ฟ๐—ฒ๐—บ๐—ถ๐˜‚๐—บ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ | ๐—œ๐—บ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฎ๐˜๐—ฒ ๐——๐—ฒ๐—น๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—”๐˜ƒ๐—ฎ๐—ถ๐—น๐—ฎ๐—ฏ๐—น๐—ฒ ๐—ฎ๐˜ -

https://www.transparencymarketresearch.com/checkout.php?rep_id=78383<ype=S

The enzyme linked immunosorbent assay (ELISA) segment currently dominates the market, thanks to its high accuracy and cost-effectiveness. ELISA-based fecal calprotectin tests have the potential to detect low levels of calprotectin and differentiate between IBD and non-IBD conditions.

In terms of regional dynamics, Europe is at the forefront of the fecal calprotectin test market due to the high prevalence of IBD, advanced healthcare infrastructure, and the presence of key market players. Meanwhile, Asia Pacific is poised to exhibit the fastest growth during the forecast period, driven by a large patient base in countries such as India and China, along with rising awareness about IBD and colorectal cancer.

๐— ๐—ผ๐—ฟ๐—ฒ ๐—ง๐—ฟ๐—ฒ๐—ป๐—ฑ๐—ถ๐—ป๐—ด ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜๐˜€ ๐—ฏ๐˜† ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—ฝ๐—ฎ๐—ฟ๐—ฒ๐—ป๐—ฐ๐˜† ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต -

Dental 3D Printing Market

https://www.globenewswire.com/news-release/2023/06/09/2685744/0/en/Dental-3D-Printing-Market-to-register-a-9-CAGR-from-2023-to-2031-expected-to-accumulate-a-Valuation-of-USD-2-9-billion-TMR-Report.html

Cardiac Implantable Electronic Devices Market

https://www.globenewswire.com/news-release/2023/06/12/2686467/0/en/Cardiac-Implantable-Electronic-Devices-Market-Surpasses-USD-16-1-Bn-by-2031-Owing-to-Surge-in-Adoption-of-Implantable-Loop-Recorder-Transparency-Market-Research.html

๐—”๐—ฏ๐—ผ๐˜‚๐˜ ๐—จ๐˜€ ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—ฝ๐—ฎ๐—ฟ๐—ฒ๐—ป๐—ฐ๐˜† ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜ ๐—ฅ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

๐—–๐—ผ๐—ป๐˜๐—ฎ๐—ฐ๐˜ ๐—จ๐˜€

Nikhil Sawlani

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fecal Calprotectin Test Market New Highs - Current Trends and Growth Drivers 2023 here

News-ID: 3185194 • Views: โ€ฆ

More Releases from Transparency Market Research

Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 Billion by 2035 | Transparency Market Research
Global SiC Ceramics Market Poised for Robust Growth, Projected to Reach USD 3.1 โ€ฆ
The global silicon carbide (SiC) ceramics market continues to demonstrate strong growth potential, underpinned by accelerating demand from advanced industrial and electronic applications. Valued at US$ 1.8 Billion in 2024, the market is projected to reach US$ 3.1 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.2% during the forecast period from 2025 to 2035. This steady expansion reflects the increasing importance of SiC ceramics asโ€ฆ
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising Demand for Bio-Based Chemicals and Expanding Foundry Industry | TMR
Furfuryl Alcohol Market to Reach USD 1.34 Billion by 2035, Supported by Rising D โ€ฆ
The global Furfuryl Alcohol Market was valued at US$ 624.3 million in 2024 and is projected to reach US$ 1,341.2 million by 2035, expanding at a compound annual growth rate (CAGR) of 7.2% from 2025 to 2035. This growth is primarily driven by the rising demand for bio-based and sustainable chemicals, along with the steady expansion of the foundry and metal casting industry, particularly across emerging economies in Asia Pacific. Gain aโ€ฆ
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by 2035 at a CAGR of 3.5% Driven by Infrastructure Expansion and Climate-Resilient Concrete Demand
Air-Entraining Agents Market Outlook 2035: Forecast to Reach US$ 2.48 Billion by โ€ฆ
The global Air-Entraining Agents (AEAs) Market was valued at US$ 1.70 billion in 2024 and is projected to reach US$ 2.48 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2035. This steady growth trajectory reflects the essential role AEAs play in modern concrete formulations, particularly in infrastructure projects that demand long-term durability, freeze-thaw resistance, and improved workability. Despite being a mature segment withinโ€ฆ
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn by 2035 at a CAGR of 4.2%
A2P SMS Market Outlook 2035: Expanding from US$ 71.2 Bn in 2024 to US$ 117.0 Bn โ€ฆ
The global Application-to-Person (A2P) SMS market is entering a phase of steady and resilient expansion, driven by the growing need for secure, reliable, and real-time communication between enterprises and consumers. Valued at US$ 71.2 Bn in 2024, the market is projected to reach US$ 117.0 Bn by 2035, expanding at a CAGR of 4.2% from 2025 to 2035. Despite the rise of internet-based messaging platforms, A2P SMS continues to maintainโ€ฆ

All 5 Releases


More Releases for IBD

Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD An โ€ฆ
Ace Therapeutics launched its translational imaging services specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. New York, USA - May 28, 2025 - Ace Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies. Image: https://www.getnews.info/uploads/3c0755ac659fa5075e809ffd1b893496.jpg Imaging techniques play a crucialโ€ฆ
Inflammatory Bowel Disease (IBD) Market Size, Growth Insights, and Future Trends
Inflammatory Bowel Disease (IBD) continues to pose significant challenges for individuals and healthcare systems worldwide. With its increasing prevalence, the demand for effective treatments is driving market growth. The IBD treatment market is projected to grow from USD 19.91 billion in 2023 to USD 33.19 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period. Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149 Key Market Highlights โ€ข Crohn's Disease Dominates: Crohn's diseaseโ€ฆ
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 โ€ฆ
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohnโ€™s disease,โ€ฆ
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohnโ€™s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios. Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xxโ€ฆ
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 โ€ฆ
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohnโ€™s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohnโ€™s disease and ulcerative colitis in the US was 201 and 238 perโ€ฆ
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For โ€ฆ
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex andโ€ฆ